The Surprising Shift in Big Pharma: Why Top Companies Are Betting on Chinese Innovations
U.S. pharma companies increasingly focus on China, seeking innovative therapies and faster development timelines. In 2024, 30% of Big Pharma deals involved Chinese companies,
